Role of prostaglandin E2 and leukotriene B4 in skin reaction induced by transdermal application of propranolol

Biological and Pharmaceutical Bulletin

Volumn 23, Issue 2, 2000, Pages 208-212

  Kobayashi, Ichiro ^a   Hosaka, Kyoko ^a   Maruo, Hiroki ^a   Saeki, Yuji ^a   Kamiyama, Masashi ^a   Konno, Chohachi ^a   Gemba, Munekazu ^b  

^a NITTO DENKO CORPORATION   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Dermal application; Edema; Erythema; Leukotriene B4; Propranolol; Prostaglandin E2

Indexed keywords

DEXAMETHASONE; INDOMETACIN; LEUKOTRIENE B4; PROLACTIN; PROPRANOLOL; PROSTAGLANDIN E2; ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLORIMETRY; CONTROLLED STUDY; DRUG ANTAGONISM; EDEMA; ERYTHEMA; GUINEA PIG; MALE; NONHUMAN; PATCH TEST; PROLACTIN RELEASE; SKIN MANIFESTATION; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG ERUPTION; INTRADERMAL DRUG ADMINISTRATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, TOPICAL; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTI-INFLAMMATORY AGENTS; DINOPROSTONE; DRUG ERUPTIONS; EDEMA; GUINEA PIGS; INDICATORS AND REAGENTS; LEUKOTRIENE B4; MALE; PROPRANOLOL; SKIN;

EID: 0033622196     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.23.208     Document Type: Article

References (24)

1. Krishna R., Pandit J. K., Biopharmaceutics Drug Disposition, 14, 785-788 (1993).
2. Krishna R., Pandit J. K., Drug Dev. Ind. Pharm., 20, 2459-2465 (1994).
3. Kobayashi I., Hosaka K., Saeki Y., Maruo H., Kamiyama M., Konno C., Gemba M., Biol. Pharm. Bull., 21, 938-944 (1998).
4. Kobayashi I., Hosaka K., Saeki Y., Maruo H., Kamiyama M., Konno C., Gemba M., Biol. Pharm. Bull., 20, 421-427 (1997).
5. Williams T. J., Peck M. J., Nature (London), 270, 530-532 (1977).
6. Ikeda K., Tanaka K., Katori M., Prostaglandins, 10, 747-758 (1975).
7. Johnston M. G., Hay J. B., Movat H. Z., Agents Actions, 6, 705-711 (1976).
8. Williams T. J., Morley J., Nature (London), 246, 215-217 (1973).
9. Palmer R. M. J., Stepney R. J., Higgs G. A., Eakins K. E., Prostaglandins, 20, 411-418 (1980).
10. Aked D. M., Foster S. J., Br. J. Pharmacol., 92, 545-552 (1987).
11. Camp R., Russell Jones R., Brain S., Woollard P., Greaves M., J. Invest. Dermatol., 82, 202-204 (1984).
12. Bray M. A., Cunningham F. M., Ford-Hutchinson A. W., Smith M. J. H., Br. J. Pharmacol., 72, 483-486 (1981).
13. Draize J. H., Woodard G., Calvery H. O., J. Pharmacol. Exp. Ther., 83, 377-390 (1944).
14. Inoue H., Mori T., Koshihara Y., Prostaglandins, 36, 731-739 (1988).
15. Kobayashi I., Hosaka K., Saeki Y., Maruo H., Kamiyama M., Konno C., Gemba M., Biol. Pharm. Bull., 19, 839-844 (1996).
16. Black A. K., Fincham N., Greaves M. W., Hensby C. N., Br. J. Clin. Pharmacol., 11, 109-110 (1981).
17. Synder D. S., Prostaglandins, 11, 631-643 (1976).
18. Ohuchi K., Sato H., Tsurufuji S., Biochim. Biophys. Acta, 424, 439-448 (1976).
19. Harada Y., Tanaka K., Uchida Y., Ueno A., Oh-ishi S., Yamashita K., Ishibashi M., Miyazaki H., Katori M., Prostaglandins, 23, 881-895 (1982).
20. Simmons P. M., Salmon J. A., Moncada S., Biochem. Pharmacol., 32, 1353-1359 (1983).
21. Ziboh V. A., Acta Dermatovener, 74, 56-60 (1975).
22. Crofford L. J., Wilder R. L., Ristimaki A. P., Sano H., Remitters E. F., Epps H. R., Hla T., J. Clin. Invest., 93, 1095-1101 (1994).
23. Ueno A., Tanaka K., Katori M., Prostaglandins, 26, 493-504 (1983).
24. Issekutz A. C., Lab. Invest., 45, 234-240 (1981).